Adiposity rebound in very-low-birth-weight infants

Koryo Nakayama1, Go Ichikawa1, Junko Naganuma1

  • 1Department of Pediatrics, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi, Japan.

Insights

Early adiposity rebound (AR) in very-low-birth-weight infants (VLBWIs) is linked to higher BMI percentiles by age seven. This finding suggests early AR predicts future obesity in VLBWIs.

Area of Science:

  • Pediatrics
  • Neonatology
  • Public Health

Background:

  • Adiposity rebound (AR), an increase in BMI after a nadir, is a critical developmental marker.
  • Early AR (before age five) is a known risk factor for childhood obesity and metabolic syndrome.
  • The prevalence and implications of early AR in very-low-birth-weight infants (VLBWIs) remain understudied.

Purpose of the Study:

  • To investigate the occurrence and impact of early adiposity rebound in VLBWIs.
  • To determine if early AR in VLBWIs predicts later obesity risk.

Main Methods:

  • Retrospective analysis of medical records for VLBWIs born between 2008-2010.
  • Tracking height and weight from birth to seven years to determine AR age and BMI percentile.
  • Comparing BMI percentiles at age seven and BMI changes between early AR (<5 years) and normal AR (≥5 years) groups using ANOVA.

Main Results:

  • The study identified 38 early AR cases and 62 normal AR cases among VLBWIs, with a prevalence similar to normal birth weight infants.
  • VLBWIs with early AR exhibited significantly higher BMI percentiles at age seven compared to those with normal AR (44.6 vs. 14.4).
  • Analysis of variance confirmed significantly greater BMI changes in the early AR group (p=0.024).

Conclusions:

  • Early adiposity rebound in very-low-birth-weight infants is a significant predictor of future obesity.
  • These findings highlight the importance of monitoring AR in VLBWIs for early identification of obesity risk.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
691
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
13
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
13
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.8K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
721